Biote (BTMD) Notes Payables (2020 - 2022)
Biote's quarterly Notes Payables came in at $72800.0 in Q1 2022, down 40.57% quarter-over-quarter from $122500.0 in Q4 2020.
Biote has reported Notes Payables for 2 years, with the latest figure at $72800.0 in Q1 2022.
- For the quarter ending Q1 2022, Notes Payables changed N/A year-over-year to $72800.0; the trailing twelve-month figure through Mar 2022 stood at $72800.0 (changed N/A YoY), and the FY2020 full-year result was $122500.0, changed N/A from the prior year.
- Notes Payables for Q1 2022 stood at $72800.0, down from $122500.0 in the prior quarter.
- The five-year high for Notes Payables was $122500.0 in Q4 2020, with the low at $72800.0 in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 84.64 Bn | 87.02 Bn | 16.26 Bn |
| 2 | Tenet Healthcare | 15.22 Bn | 14.39 Bn | 4.41 Bn |
| 3 | Davita | 13.10 Bn | 13.96 Bn | 1.07 Bn |
| 4 | Encompass Health | 10.50 Bn | 11.12 Bn | 1.34 Bn |
| 5 | Ensign | 9.69 Bn | 9.09 Bn | 293.37 Mn |
| 6 | Universal Health Services | 8.92 Bn | 8.88 Bn | 3.21 Bn |
| 7 | Fresenius Medical Care AG | 7.31 Bn | 4.93 Bn | 22,843.10 Bn |
| 8 | Chemed | 5.83 Bn | 5.81 Bn | 215.76 Mn |
| 9 | Pacs | 5.76 Bn | 5.51 Bn | 345.96 Mn |
| 10 | Biote | 61.29 Mn | 64.11 Mn | 30.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 72,800.00 |
| Dec 31, 2020 | 122,500.00 |